期刊名称：JOURNAL OF PHARMACY AND PHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Journal of Pharmacy and Pharmacology (JPP), edited by Professors Duncan Craig, from the School of Chemical Sciences and Pharmacy, The University of East Anglia, and David Jones, from the School of Pharmacy, The Queen’s University of Belfast, is continually evolving to reflect recent developments in the pharmaceutical sciences. The journal is read world-wide and boasts a respected international editorial board. Over the past couple of years' the journal's focus has shifted to encompass topics of recent interest (see below) whilst still maintaining its core strengths.
Original research papers, critical reviews and communications are published monthly on those sciences which contribute to the development and evaluation of medicinal substances.
Instructions to Authors
JPP EDITORIAL OFFICE
Editorial Office
Journal of Pharmacy and Pharmacology
School of Pharmacy
The Queen's University of Belfast
97 Lisburn Road
Belfast
BT9 7BL
Tel: 02890 272185
Fax: 02890 272028
Email: jpp@qub.ac.uk
SUBMISSION PROCEDURE
Editorial Policy
The Journal of Pharmacy and Pharmacology publishes manuscripts pertaining to the design, delivery and mechanism of action of drugs and dosage forms with a view to developing and improving current therapeutic drug strategies.
Original research papers, critical reviews, minireviews, short communications and letters are accepted on the understanding that they are subject to editorial revision, that their content has not been published elsewhere and that once accepted for publication the licence to publish the text is assigned to the Journal of Pharmacy and Pharmacology. Submissions will be subject to peer review and decisions regarding acceptability will be made on the basis of the quality of science, the contribution of the work to the field, the suitability of the work for the journal and the presentation of the manuscript.
We aim to present authors with an initial decision regarding the acceptability of submitted papers within eight weeks of receipt of the manuscript and to maintain an average time from submission to publication of within seven months.
Submission Requirements
Please submit four copies of the manuscript along with a copy of the paper on disk. Consult a current issue of the Journal for typographical style, Journal conventions, use of headings, lay-out of tables and citation of references. Authors are invited to suggest up to three referees along with their corresponding contact details (email essential) and up to three keywords regarding their respective reseach areas. Please note that the Editors reserve the right to return manuscripts which do not fall within the priority remit of the Journal prior to consultation with referees.
Sample Paper
Structuring your paper
Title page - Please give the names, addresses and further contact details (including telephone and fax numbers and E-mail) of all authors, also indicating the correspondence author. A shortened title (not more than 50 characters) is also required.
Abstract - Should be structured to consist of 1 paragraph stating aims, methodology, results (including specific data where appropriate) and conclusions. Approximately 200 words.
Introduction - Should provide a background to the study and should clearly state the specific aims of the study. Please ensure that any abbreviations and all symbols used in equations are fully defined. Approximately 1000 words.
Materials and Methods - Should describe the materials and methodology used in sufficient detail to allow the study to be replicated. Please include details of ethical approval in this section. Approximately 500-1000 words.
Results and Discussion - Results may be presented in isolation from the Discussion or as an amalgamated section depending on the nature of the study. Only results of the study should be included here. It is essential to include statistical analyses or other indicators to enable assessment of the variance of replicates of the experiments. Data should not be repeated in Figures and Tables. Under most circumstances a maximum of seven Figures and/or Tables and a maximum word length of 1500 are appropriate.
Conclusions - A brief conclusions section should be included summarising the salient findings of the study. Authors are strongly advised to emphasise the contribution made to the field by their study in this section. Approximately 300 words.
Tables - Each table must start on a separate sheet. Tables should not be ruled. Each table legend, in paragraph form, should briefly describe the content and define any abbreviations used.
Figures - Please keep the number of figures to a minimum. Figures can be submitted on disk but they must be accompanied by a top quality hard-copy version. Legends should not appear on the figures but should be typed on a separate sheet. All figures and photographs should be suitable for black and white reproduction.
Acknowledgements and Funding - This is used to acknowledge financial and other assistance to the work.
References - The Journal uses the Harvard reference system. All citations in the text must appear in the reference list and vice versa. Unpublished work should not be included in the reference list unless accepted for publication. References in the text are cited by author and year, if there are three or more authors use et al. If the year is the same for several references identify these with a,b,c etc., (eg Brown 1999a, b, c) both in the text and in the reference list. In the reference list, arrange the reference in the order: names(s) (all), date, title of article, serial title (italics), volume (bold), first and last pagenumbers, with no underlining, thus:
Brown, B., Green, G. (1986) The effects of dyes on flexible films. J. Pharm. Pharmacol. 36: 990-995
Where there are more than 2 authors ensure that all authors are listed in the reference list. References are listed alphabetically under the first authors surname, but if there are several references to three or more authors with the same first author, arrange these chronologically regardless of the alphabetical order of surnames other than the first. These 'alphabetic-chronological' references should be placed after references to Brown alone or Brown and X. Serial titles should be abbreviated in accordance with ISO 833. ANSI Z39.5 (1969), and BS 4148 (1970, 1975) or with lists such as index medicus or BIOSIS. One-word titles are never abbreviated. References to books should be asfollows:
Flower, R. J., Moncada, S., Vane, J. R. (1985) Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of gout. In: Gilman, A. G., Goodman, L. S., Rall, T. W., Murad, F. (eds) The pharmacological basis of therapeutics, 7th edn. New York: Macmillan, pp. 674-715
Style guides - Journal abbreviations
Full Research Papers
While the Journal of Pharmacy and Pharmacology does not operate a policy of limiting the length of submissions, authors are urged to be succinct and to use the minimum number of tables and figures necessary and to avoid repetition of information between these two media. Given the competition for space within the journal, the length of a submission in relation to its likely contribution will be taken into account with regard to acceptability. Please note that studies involving animals or human volunteers must include details of ethical approval. Papers that do not comply with internationally accepted ethical criteria will not be accepted for publication.
Critical Reviews
These are normally commissioned by invitation from the Editors but suggestions are welcome. Please contact the Editorial office before submitting a review article.
Minireviews
Letters that bring a specific feature of an issue of interest to the attention of readers are encouraged. Maximum 1000 words.
Communications
Short reports (usually up to 2000 words with a maximum of four Figures/Tables) that describe particularly pertinent findings may be submitted as a rapid communication that, once accepted, will receive publishing priority. Authors are asked to include a covering letter outlining why the paper merits rapid publication. Please note that this section is not intended for short studies per se but for findings that should be brought rapidly to the attention of the readership.
Letters to the Editor
These are discussion articles of up to 5000 words in length. Please contact the Editorial office prior to submission of such articles.
Free Copy and Offprints
A copy of the Journal containing the published article is sent to the corresponding author along with 25 free offprints of the published article. Further offprints may be purchased in multiples of 50 by completing the order form sent with the page proofs.
Submission Address
Editorial Office
Journal of Pharmacy and Pharmacology
The Queen's University of Belfast
97 Lisburn Road
Belfast
BT9 7BL
Tel: 02890 272185
Fax: 02890 272028
Email: jpp@qub.ac.uk
CONTACT US PAGE
STYLE GUIDES
Journal abbreviations:
PEER REVIEW PROCESS
(Editorial Policy Regarding the Acceptability of Submitted Papers)
All submitted papers will be scrutinised in the following manner:
a) Initial editorial screening - papers will be examined by the Editors to ensure that the manuscript falls within the priority remit of the Journal. Those papers that do not fall within this remit will be returned to the authors as rapidly as possible to facilitate resubmission to a more suitable publication.
b) Submission to referees - the manuscript will be sent to referees who will have been previously contacted to establish their willingness to review the paper. Authors who have suggested three referees, as indicated in the Notice to Contributors, may usually expect one of these individuals to be contacted, provided full contact details have been given (including e mail address). At least two sets of referees comments will be utilised.
c) Initial editorial decision - the editors will re-examine the manuscript in the light of the recommendations made by the referees. One of the following decisions will be made:
- accept as received
- accept subject to satisfactory completion of minor amendments (an editorial report is usually included at this stage)
- reconsider after major revision (full revised manuscript requested)
- reconsider after major revision (response to referees comments requested prior to preparation of a full revised manuscript)
- reject
Please note that papers are judged not only on the presence or absence of flaws to the work but also on the likely contribution to the field. Those manuscripts that represent only a small incremental increase in the respective knowledge base will not be accepted irrespective of whether the work has been conducted in a sound manner.
d) Revised version or response sent back to referees as appropriate - the editors reserve the right to make a decision on the paper without consulting the referees for a second time. Members of the Editorial Board may also be consulted at this stage. Final decisions will be reported back to the authors as quickly as possible.
e) Accepted manuscripts sent to press - the publishers will process accepted papers and contact authors with proofs and any further queries. In order to expedite publication it is essential that authors return proofs rapidly; it is the responsibility of the authors to ensure that arrangements are made for the proofs to be scrutinised or the publishers to be contacted in the event of a protracted absence from the workplace. Failure to return proofs promptly will result in delays to the publication of the manuscript.
f) Referees will be thanked and informed of the final decision - it is our intention to introduce a system of sending the referees copies of all the submitted reports in the near future.
YOUR PAPER IN PRODUCTION
Acceptance
Once your paper has undergone all final revisions in-line with the referee and editorial comments and has been finally accepted by the Editors it will be passed to the Production Office. All future contact should be with the Journal's Production Editor.
Editing
Your paper will undergo a final edit by a fully trained copyeditor who will be checking the readability of the paper, consistency of references, figures, tables and style. This process often results in author queries, these are usually sent out as an appendment to the page proofs.
Proofing
Once edited, the paper will be allocated to an issue and will be sent for typesetting. You will receive PDF proofs of your paper via email, please ensure an up-to-date email address is supplied with your final paper. You will also receive a Licence to Publish form and Offprint Order form. The proofs need to be checked thoroughly and returned to the Production Editor within 3 days of the email being sent.
Proofreading Guide
Once the proofs have been received, the following things should be checked:
- Typesetting or conversion errors
- Figures and tables - are they in the correct place Are they accurately reproduced?
- Editing - language, house style, scientific nomenclature
- There may be a list of queries attached to your proofs, if so please make sure all queries are answered and that they are returned with the marked proof.
Marking clear corrections:
- To delete a character, word or block of text, cross out the material and write 'delete' in the margin.
- If something has been marked for deletion and you decide to leave it, underscore the material in the text and write 'stet' in the margin.
- If you wish to add some text, place a Y in the text and write the addition in the margin. If there is not enough room for the addition please attach a separate sheet and indicate clearly where it should be inserted in the text.
The proofs should be returned to the Production Editor within 3 days of the email being sent, by email or fax.
Contact us
Helen Bond
Production Editor
Pharmaceutical Press
1 Lambeth High Street
London
SE1 7JN
Tel: +44 (0)20 7572 2355
Fax: +44 (0)20 7572 2509
Email: hbond@rpsgb.org.uk
LICENCE TO PUBLISH
Most journal publishers insist that copyright in material submitted to a journal is assigned to the publisher or the journal. However, from January 2001, the Journal of Pharmacy and Pharmacology adopted a policy of contributors assigning to the Pharmaceutical Press a licence to publish their work. This policy, currently used by only a handful of scientific journals, means that copyright remains with the authors of the work giving the originators much greater control over the use of their published material provided it does not conflict with the publishers commercial interests. In practice, this policy means that authors may re-use their work for non-commercial purposes without asking permission of the publisher. An author, for example, may thus post the text of their article on a personal or institutional website, or may re-use their work within a chapter in a book. An example of the 'Licence to Publish' form used by the Journal of Pharmacy and Pharmacology may be downloaded.
Editorial Board
Professor Duncan Craig, The University of East Anglia, UK
Professor David Jones, The Queen's University of Belfast, UK
Editorial Assistant
Grainne McCarron, The Queen's University of Belfast, UK
Board members
K L AUDUS, University of Kansas, KS, USA
B W BARRY, University of Bradford, UK
N BODOR, University of Florida, FL, USA
D BRAYDEN, University College Dublin, Ireland
K J BROADLEY, University of Cardiff, UK
G BROOKS, University of Reading, UK
D J BURGESS, University of Connecticut, CT, USA
W N CHARMAN, Monash University, Australia
Y W CHIEN, Kaohsiung Medical University, Taiwan
D A COWAN, King’s College London, UK
S P DENYER, University of Brighton, UK
C DOHERTY, AstraZeneca, UK
J DRESSMAN, Johann Wolfgang von Goethe-Universitat, Germany
A T FLORENCE, University of London, UK
J L FORD, Liverpool John Moores University, UK
E P GOLDBERG, University of Florida, FL, USA
S P GORMAN, The Queen’s University of Belfast, UK
D J GREENBLATT, Tufts University School of Medicine, MA, USA
M J GROVES, University of Illinois at Chicage, IL, USA
R H GUY, Centre Interuniversitaire de Recherche et d’enseignement, France
B HANCOCK, Pfizer Inc., CT, USA
M HEINRICH, University of London, UK
A HOLT, Alviva Biopharmaceuticals Inc., SK, Canada
P J HOUGHTON, King’s College London, UK
P G JENNER, King’s College London, UK
I W KELLAWAY, University of London, UK
H LENNERNAS, University of Uppsala, Sweden
H I MAIBACH, University of California Medical Center, CA, USA
T K MANDAL, Xavier University of Louisiana, LA, USA
C O'DRISCOLL, University of Dublin, Ireland
C PETTS, Hoddesdon, UK
J W PHILLIS, Wayne State University School of Medicine, MI, USA
T RADES, University of Otago, New Zealand
K D RAINSFORD, Sheffield Hallam University, UK
A ROLLAND, Valentis Inc., TX, USA
K SHAKESHEFF, University of Nottingham, UK
B TESTA, University of Lausanne, Switzerland
A TSUJI, Kanazawa University, Japan
R WAIGH, University of Strathclyde, UK
A C WILLIAMS, University of Bradford, UK
| 
